Navidea forms joint venture with rheumatology startup to target arthritis drugs
Story excerpt provided by Columbus Business First.
Written by Carrie Ghose.
Navidea Biopharmaceuticals Inc. took a first step toward developing radioactive drugs to treat disease instead of just detect it with the formation of a joint venture with an early stage pharmaceutical company focused on arthritis.
Click here to read the complete article.
Originally published July 17, 2014.
Leave a Reply